Abstract:To have a comprehensive understanding of epidemiology and antifungal susceptibilities in pathogenic yeasts, the China Antifungal Resistance Surveillance Trial (CARST-fungi) study was conducted. All yeast isolates were identified by ribosomal DNA sequencing. Antifungal susceptibilities were performed using CLSI M27-A4 broth microdilution method. Sequence and expression level of resistant-related genes in resistant/non-wide-type (NWT) Candida isolates were analyzed. Totally 269 nonduplicate yeast isolates from 261 patients were collected. About half of the yeast isolates (127, 47.2%) were recovered from blood, followed by ascetic fluid (46, 17.1%). C. albicans remained the most prevalent (120, 44.6%), followed by C. parapsilosis complex (50, 18.6%), C. tropicalis (40, 14.9%), and C. glabrata (36, 13.4%). Fourteen (11.7%) C. albicans isolates and 1 (2.0%) C. parapsilosis isolate were resistant/NWT to triazoles. Only 42.5% (17/40) C. tropicalis were susceptible/WT to all the triazoles, with 19 (47.5%) isolates NWT to posaconazole and 8 (20%) cross-resistant to triazoles. Among C. glabrata , 20 (55.6%) and 8 (22.2%) isolates were resistant/NWT to voriconazole and posaconazole, respectively, and 4 (10.3%) isolates were cross-resistant to triazoles. Isavuconazole was the most active triazole against common Candida isolates. Except for 2 isolates of C. glabrata cross-resistant to echinocandins which were also NWT to POS and defined as multidrug-resistant, echinocandins exhibit good activity against common Candida species. All isolates were WT to AMB. For less common species, Rhodotorula mucilaginosa exhibited high MICs to echinocandins and FLC, and 1 isolate of Trichosporon asahii showed high MICs to all the antifungals except AMB. Among triazole-resistant Candida isolates, ERG11 mutations were detected in 10/14 C. albicans and 6/23 C. tropicalis , while 21/23 C. tropicalis showed MDR1 overexpression. Overexpression of CDR1 , CDR2 , and SNQ2 exhibited in 14, 13, and 8 of 25 triazole-resistant C. glabrata isolates, with 5 isolates harboring PDR1 mutations and 2 echinocandins-resistant isolates harboring S663P mutation in FKS2 . Overall, the CARST-fungi study demonstrated that although C. albicans remain the most predominant species, non- C. albicans species accounted for a high proportion. Triazole-resistance is notable among C. tropicalis and C. glabrata . Multidrug-resistant isolates of C. glabrata and less common yeast have been emerging.

[25S Rdna Genotype and Antifungal Susceptibility of Vaginal Candida Albicans].

Analysis on Hyphal Form of Candida Albicans by Randomly Amplified Polymorphic DNA

Antifungal Susceptibility and Genotypes of Candida Albicans Strains from Patients with Vulvovaginal Candidiasis

Biased Genotype Distributions of Candida albicans Strains Associated with 649 Clinical Vulvovaginal Candidiasis in China

Resistant Mechanisms of Candida albicans to Azoles

In vitro adherence activity of different genotypes of Candida albicans from patients with vulvovaginal candidiasis

Analysis of Resistance and Sensitivity of 1 200 Strains of Vulvovaginal Candidiasis in China to Five Common Antifungal Drugs

Genotyping of Candida albicans Isolated from Different Body Sites of Women Suffering from Candidal Vulvovaginitis

Antifungal Susceptibility Testing of Candida Albicans Isolated from Recurrent Vulvovaginal Candidiasis

[Analysis of Homology and Drug Sensitivity of Vaginal Isolates of 10 Patients with Recurrent Vulvovaginal Candidiasis in Recurrent Episodes].

Correlation Between Azole Susceptibilities, Genotypes, and ERG11 Mutations in Candida Albicans Isolates Associated with Vulvovaginal Candidiasis in China

Genotype Distribution of Candida Albicans Strains Associated with Different Conditions of Vulvovaginal Candidiasis, As Revealed by Microsatellite Typing.

Species Distribution and in Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.

Fluconazole-resistant Candida Albicans Strains Exhibited Cross-resistance to Other Azole Antifungal Agents in Vitro

Genetic diversity in Fluconazole-resistant and -susceptible oral Candida albicans isolated from patients with Sjgren's syndrome

Genotyping and Antifungal Susceptibility of Candida Albicans Isolates from AIDS Patients

Clinical Characteristics and Antifungal Susceptibility of Candida Nivariensis from Vulvovaginal Candidiasis

Genotypes analysis and antifungal susceptibility of Candida albicans strains isolated from women with vaginal candidiasis in Jordan using PCR targeting 25SrDNA and ALT repeat sequences of the RPS

Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012

Invasive Candidiasis in Intensive Care Units in China: in Vitro Antifungal Susceptibility in the China-SCAN Study

Molecular identification, antifungal susceptibility, and resistance mechanisms of pathogenic yeasts from the China antifungal resistance surveillance trial (CARST-fungi) study